Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C

被引：0
|
作者：
Assmar, Mehdi [1 ]
Yeganeh, Sara [1 ]
Mansourghanaei, Fariborz [2 ]
Amirmozafari, Nour [3 ]
机构：
[1] Islamic Azad Univ, Dept Microbiol, Lahijan, Iran
[2] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran
[3] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran
来源：
IRANIAN JOURNAL OF PUBLIC HEALTH | 2016年 / 45卷 / 12期
关键词：
Tumor markers; Hepatitis B; Hepatitis C; ELISA; CLINICAL-IMPLICATIONS; ALPHA-FETOPROTEIN; LIVER-DISEASE; SERUM; CANCER; EPIDEMIOLOGY; PREVALENCE; INFECTION; ANTIGEN;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Background: This study aimed to determine the role of tumor markers AFP, CA15-3, CA125, CA19-9 and CEA in patients with hepatitis B and C. Methods: This descriptive cross-sectional study was performed from Oct 2012 to Oct 2014. Serum samples of 129 patients with hepatitis B and C referred to Guilan Liver and Digestive Disease Research Center in Rasht, Iran were collected and checked for the existence of the listed tumor markers by ELISA. Results: No increase in serum levels of tumor marker CA19-9, CEA and CA15-3 were seen in patients with hepatitis (P>0.05). In patients with hepatitis B, increase in CA125 were observed (P=0.03). In hepatitis C patients, there was an increase in AFP levels (P=0.03). Conclusion: The levels of AFP and CA125 markers were high in hepatitis C and hepatitis B, respectively. However, the increased levels were not seen is malignancy. Due to the small sample size, further study is necessary to find the reasons of the increase.
引用
收藏
页码：1645 / 1651
页数：7
相关论文
共 50 条
  • [31] Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study
    Junxian Li
    Luyang Liu
    Ziwei Feng
    Xin Wang
    Yubei Huang
    Hongji Dai
    Liwen Zhang
    Fangfang Song
    Dezheng Wang
    Pengyu Zhang
    Baoshan Ma
    Haixin Li
    Hong Zheng
    Fengju Song
    Kexin Chen
    Breast Cancer, 2020, 27 : 621 - 630
  • [32] Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study
    Li, Junxian
    Liu, Luyang
    Feng, Ziwei
    Wang, Xin
    Huang, Yubei
    Dai, Hongji
    Zhang, Liwen
    Song, Fangfang
    Wang, Dezheng
    Zhang, Pengyu
    Ma, Baoshan
    Li, Haixin
    Zheng, Hong
    Song, Fengju
    Chen, Kexin
    BREAST CANCER, 2020, 27 (04) : 621 - 630
  • [33] Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9
    Gao, Y. -C.
    Yuan, Z. -B.
    Yang, Y. -D.
    Lu, H. -K.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2007, 67 (07): : 741 - 747
  • [34] CEA, CA125 and CA19-9 levels in congenital gastrointestinal anomalies
    Baykal-Erkilic, A
    Erkiliç, M
    Melikoglu, M
    Aksu, A
    TURKISH JOURNAL OF PEDIATRICS, 1999, 41 (04) : 473 - 481
  • [35] Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei
    Nummela, Pirjo
    Leinonen, Hannele
    Jarvinen, Petrus
    Thiel, Alexandra
    Jarvinen, Heikki
    Lepisto, Anna
    Ristimaki, Ari
    HUMAN PATHOLOGY, 2016, 54 : 47 - 54
  • [36] Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers
    Unic, Adriana
    Derek, Lovorka
    Stancin, Nevenka
    Serdar, Tihana
    Sprajc, Novka
    Romic, Zeljko
    BIOCHEMIA MEDICA, 2010, 20 (01) : 82 - 89
  • [37] 联合检测肿瘤标志物AFP、CEA、CA125、CA19-9、CA15-3在妇科疾病诊断中应用分析
    赵红光
    姚风芳
    申新丽
    农垦医学, 2006, (04) : 263 - 264
  • [38] CEA、CA125、CA15-3和CA19-9检测在良恶性胸腔积液鉴别诊断中的价值
    姚燕峰
    张雪丹
    放射免疫学杂志, 2012, 25 (03) : 348 - 350
  • [39] CA125、CA15-3及CA19-9联检对卵巢癌诊断的价值
    邹洁洁
    放射免疫学杂志, 2013, 26 (06) : 831 - 832
  • [40] Analysis of AFP, CEA, CA19-9, CA125 and PSA levels of in-patient at General Surgery Clinic
    Surmegozluer, Onur
    Ulucay, Omer
    KONURALP TIP DERGISI, 2013, 5 (03): : 13 - 17
12345